Cite
HARVARD Citation
Ishikawa, T. et al. (n.d.). BRCAness is beneficial for indicating triple negative breast cancer patients resistant to taxane. European journal of surgical oncology. 42 (7), pp. 999-1001. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ishikawa, T. et al. (n.d.). BRCAness is beneficial for indicating triple negative breast cancer patients resistant to taxane. European journal of surgical oncology. 42 (7), pp. 999-1001. [Online].